Evidence map›Paper›PMID 24895308›Full record

ArticlemBio2014

Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis.

Paras Jain, Tsungda Hsu, Masayoshi Arai, Karolin Biermann, David S Thaler, Andrew Nguyen, Pablo A González, Joann M Tufariello, Jordan Kriakov, Bing Chen and 2 more

Abstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed.

  1. Article
  2. Article
  3. Polyketide synthase 12 is anbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A new Persister Enrichment Model inbioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Characterization of a novelCurrent research in microbial sciences · 2026
    Article
  16. Review
  17. Review
  18. Article
  19. Pyrazinamide killsbioRxiv : the preprint server for biology · 2025
    Article
  20. Loss of the ESX-5 secretion locus inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Paras Jain
Tsungda HsuDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Masayoshi AraiDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Karolin BiermannDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
David S ThalerDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, USA.
Andrew NguyenDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Pablo A GonzálezDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, USA.
Joann M TufarielloDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Jordan KriakovDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Bing ChenDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Michelle H Larsen
William R Jacobsjacobsw@hhmi.org.

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
"The Tuberculous Granuloma"P01AI063537 · NIAID · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI PORCELLI, STEVEN A · 2005 to 2015
$15.7M
Molecular Genetic Analysis of Mycobacterium TuberculosisR37AI026170 · NIAID · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI WILLIAM Robert JACOBS · 2004 to 2026
$7.7M
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSISR01AI026170 · NIAID · YESHIVA UNIVERSITY · PI JACOBS, WILLIAM ROBERT · 1989 to 2022
$7.1M
Vaccines for Extensively Drug Resistant TuberculosisR01AI098925 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JACOBS, WILLIAM ROBERT · 2012 to 2016
$5.8M
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSISR22AI026170 · NIAID · YESHIVA UNIVERSITY · PI JACOBS, WILLIAM ROBERT · 1989 to 1991
–
NIAID NIH HHS AI051519NIAID NIH HHS AI26170NIAID NIH HHS AI26981NIAID NIH HHS P01 AI063537NIAID NIH HHS P30 AI051519NIAID NIH HHS R01 AI026170NIAID NIH HHS R01 AI098925NIAID NIH HHS R37 AI026170
6 · The paper itself

Abstract

unlabelledSpecialized transduction has proven to be useful for generating deletion mutants in most mycobacteria, including virulent Mycobacterium tuberculosis. We have improved this system by developing (i) a single-step strategy for the construction of allelic exchange substrates (AES), (ii) a temperature-sensitive shuttle phasmid with a greater cloning capacity than phAE87, and (iii) bacteriophage-mediated transient expression of site-specific recombinase to precisely excise antibiotic markers. The methods ameliorate rate-limiting steps in strain construction in these difficult-to-manipulate bacteria. The new methods for strain construction were demonstrated to generalize to all classes of genes and chromosomal loci by generating more than 100 targeted single- or multiple-deletion substitutions. These improved methods pave the way for the generation of a complete ordered library of M. tuberculosis null strains, where each strain is deleted for a single defined open reading frame in M. tuberculosis. IMPORTANCE: This work reports major advances in the methods of genetics applicable to all mycobacteria, including but not limited to virulent M. tuberculosis, which would facilitate comparative genomics to identify drug targets, genetic validation of proposed pathways, and development of an effective vaccine. This study presents all the new methods developed and the improvements to existing methods in an integrated way. The work presented in this study could increase the pace of mycobacterial genetics significantly and will immediately be of wide use. These new methods are transformative and allow for the undertaking of construction of what has been one of the most fruitful resources in model systems: a comprehensive, ordered library set of the strains, each of which is deleted for a single defined open reading frame.

Indexed as

Gene DeletionRecombination, GeneticTransduction, GeneticAllelesBase SequenceGene ExpressionGene OrderHomologous RecombinationHumansMolecular Sequence DataMycobacteriophagesMycobacterium tuberculosisPlasmids

Identifiers

PMID24895308
PMCPMC4049104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.